CHINA RESOURCES PHARMACEUTICAL GR earnings per share and revenue

3320 earnings per share for the last semiannual are 0.44 HKD whereas the estimation was 0.46 HKD which accounts for -4.33% surprise. Company revenue for the same period amounts to 138.17 B HKD despite the estimated figure of 138.62 B HKD. Estimated earnings per share for the next semiannual are 0.24 HKD, and revenue is expected to reach 138.12 B HKD. Also watch annual changes over time to get a bigger picture of 3320 earnings per share and revenue dynamics.